Compounds > n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide
Page last updated: 2024-09-05

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Abnormality, Heart

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide has been researched along with Abnormality, Heart in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ABECASIS, I; BEREZOVSKY, M; GARIJO DE GUIMPEL, A; GUIMPEL, A; SLOER, M1

Other Studies

1 other study(ies) available for n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Abnormality, Heart

ArticleYear
[Ebstein's disease. 3 Recent cases].
    Prensa medica argentina, 1959, Dec-11, Volume: 46

    Topics: Cyclic N-Oxides; Heart Defects, Congenital

1959